• Lead, Blood
  • Lipase, Serum
  • Nickel, Serum
  • Anti-Streptolysin O (ASO)
  • C-Reactive Protein, High Sensitivity (hsCRP)
  • Aluminum, Serum
  • Neurotrophic Receptor Tyrosine Kinase 2 (NTRK2) Gene Mutation Analysis (Translocation)
  • Hepatic Function Panel (Liver Panel)
  • Group A Streptococcus (Streptococcus pyogenes) Antibody (Streptozyme), Titer
  • FoundationOne®CDx (F1CDx) and FoundationOne® Liquid CDx
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /OncoTarget™ and OncoTreat™ Test for Cancer Therapy Selection
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

OncoTarget™ and OncoTreat™ Test for Cancer Therapy Selection
Medical Test

Reference Ranges
Access to OncoTarget™ and OncoTreat™ Test for Cancer Therapy Selection is restricted.
Loading...